Why Is Terns Pharmaceuticals Stock Trading Lower After Obesity Trial Data?

Why is Meta cutting 600 AI jobs? How will US export curbs affect China? What caused Netflix’s latest earnings miss? Why is Beyond Meat stock surging again? How is Amazon using AI in delivery? What impact will NHL prediction market deal have? Why did Texas Instruments stock tumble?

Why Is Terns Pharmaceuticals Stock Trading Lower After Obesity Trial Data?

benzinga.com/news/health-care/25/10/48363614/why-terns-pharmaceuticals-stock-trading-lower-after-obesity-trial-data

On Tuesday, Terns Pharmaceuticals Inc. (NASDAQ:TERN) shared topline 12-week results from its FALCON Phase 2 trial of TERN-601.
TERN stock is struggling to find support. Check the fundamentals here
The therapy is an oral GLP-1 receptor agonist (GLP-1RA) as a potential treatment for…

This story appeared on benzinga.com, 2025-10-22 18:43:39.